Feingold syndrome
From Wikipedia, the free encyclopedia
Feingold syndrome (also called oculodigitoesophagoduodenal syndrome) is a rare autosomal dominant hereditary disorder. It is named after Murray Feingold, an American physician who first described the syndrome in 1975. Until 2003, at least 79 patients have been reported worldwide Teszas et al. 2006: "Expanding the clinical spectrum of MYCN-related Feingold syndrome" Am J Med Genet Part A 140A:2254-2256
Characteristics
Feingold syndrome is marked by various combinations of microcephaly, limb malformations, esophageal and duodenal atresias, and sometimes learning disability or mental retardationCelli et al. 2003: "Feingold syndrome: clinical review and genetic mapping" Am J Med Genet Part A 122(4):294-300. Diagnosis and treatment
The diagnosis is based on the following clinical findings:
Genetic etiology
Feingold syndrome is caused by mutations in the neuroblastoma-derived V-myc avian myelocytomatosis viral-related oncogene (MYCN; OMIM 164840 [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=164840&a=164840_AllelicVariant0001]) which is located on the short arm of chromosome 2 (2p24.1).
Next Page
This article is based on an article from Wikipedia, the free encyclopedia and is available under the terms of GNU Free Documentation License.
In the Wikipedia there is a list with all authors of this article available.